Evaluation of right ventricle and small vascular disease by using FDG-PET and BMIPP analogue imaging in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension

Evaluation of right ventricle and small vascular disease by using FDG-PET and BMIPP analogue imaging in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension - vascular disease by using FDG-PET and BMIPP analogue imaging in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000016338

Enrollment

Registered

2015-02-01

Start date

2011-10-27

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension

Interventions

FDG-PET and BMIPP analogue imaging lung biopsy in CTEPH patients

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1)regardless of age or sex 2)mPAP>25mmHg in RHC 3)CTEPH who will undergo a PEA operation 4)patients with a written informed consent form

Exclusion criteria

Exclusion criteria: 1)patients who are supposed to be unsuitable for this study by a study director

Design outcomes

Primary

Measure	Time frame
An accumulation of glucose and fatty acid in right ventricle and vasculature	—

Secondary

Measure	Time frame
Evaluation of small vascular remodeling in CTEPH and a correlation between glucose and fatty acid accumulation and pulmonary hemodynamics	—

Countries

Japan

Contacts

Public ContactSeiichiro Sakao

Graduate School of Medicine, Chiba University Department of Respirology (B2)

sakaos@faculty.chiba-u.jp043-222-7171

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026